Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $49,442 | 3,371 | 98.6% |
| Gift | $506.40 | 1 | 1.0% |
| Education | $208.79 | 17 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,552 | 288 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,520 | 223 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,878 | 234 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,486 | 184 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,280 | 129 | $0 (2024) |
| Novo Nordisk Inc | $2,199 | 198 | $0 (2024) |
| PFIZER INC. | $1,953 | 165 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,421 | 90 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,385 | 83 | $0 (2024) |
| Abbott Laboratories | $1,372 | 68 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,612 | 281 | ABBVIE INC. ($814.50) |
| 2023 | $6,680 | 379 | ABBVIE INC. ($943.26) |
| 2022 | $6,727 | 410 | ABBVIE INC. ($805.96) |
| 2021 | $7,319 | 502 | AbbVie Inc. ($1,161) |
| 2020 | $5,813 | 400 | AstraZeneca Pharmaceuticals LP ($696.30) |
| 2019 | $5,064 | 415 | AstraZeneca Pharmaceuticals LP ($520.05) |
| 2018 | $6,127 | 485 | AstraZeneca Pharmaceuticals LP ($623.72) |
| 2017 | $6,815 | 517 | AstraZeneca Pharmaceuticals LP ($737.61) |
All Payment Transactions
3,389 individual payment records from CMS Open Payments — Page 1 of 136
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $27.75 | General |
| Category: GI | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: CNS | ||||||
| 12/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.50 | General |
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Biological | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: CNS | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 171 | 433 | $65,076 | $35,626 |
| 2022 | 3 | 202 | 514 | $77,668 | $45,266 |
| 2021 | 2 | 166 | 491 | $73,593 | $44,918 |
| 2020 | 3 | 140 | 348 | $52,558 | $24,951 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 410 | $62,730 | $34,415 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $2,346 | $1,211 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 461 | $70,533 | $41,061 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 40 | $4,080 | $2,536 | 62.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,055 | $1,669 | 54.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 461 | $70,533 | $42,663 | 60.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 30 | $3,060 | $2,255 | 73.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 285 | $43,605 | $21,070 | 48.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 44 | $4,488 | $2,440 | 54.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $4,465 | $1,441 | 32.3% |
About Dr. Jin Kim, M.D
Dr. Jin Kim, M.D is a Family Medicine healthcare provider based in Rancho Cucamonga, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558371401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jin Kim, M.D has received a total of $50,157 in payments from pharmaceutical and medical device companies, with $5,612 received in 2024. These payments were reported across 3,389 transactions from 100 companies. The most common payment nature is "Food and Beverage" ($49,442).
As a Medicare-enrolled provider, Kim has provided services to 679 Medicare beneficiaries, totaling 1,786 services with total Medicare billing of $150,761. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Rancho Cucamonga, CA
- Active Since 08/09/2006
- Last Updated 07/30/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558371401
Products in Payments
- FARXIGA (Drug) $2,268
- TRELEGY ELLIPTA (Drug) $1,706
- VRAYLAR (Drug) $1,627
- JARDIANCE (Drug) $1,381
- LATUDA (Drug) $1,352
- UBRELVY (Drug) $1,247
- NURTEC ODT (Drug) $1,183
- XIFAXAN (Drug) $1,097
- REXULTI (Drug) $1,062
- LINZESS (Drug) $1,053
- Trintellix (Drug) $977.25
- RELISTOR (Drug) $855.61
- FREESTYLE LIBRE 2 (Device) $835.84
- Ozempic (Drug) $826.76
- XARELTO (Drug) $753.63
- ZIMHI (Drug) $714.03
- STIOLTO RESPIMAT (Drug) $701.97
- Horizant (Drug) $664.95
- Lucemyra (Drug) $646.77
- TRINTELLIX (Drug) $633.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rancho Cucamonga
Dr. Steven Barag, D.o, D.O
Family Medicine — Payments: $114,672
Dr. Mark Shiu, Do, DO
Family Medicine — Payments: $21,511
Sandra Force-Obrowski, M.d, M.D
Family Medicine — Payments: $16,517
Dr. Ravinder Singh, M.d, M.D
Family Medicine — Payments: $12,616
Dr. Sepehr Manavi, M.d, M.D
Family Medicine — Payments: $11,887
Dr. Theodore Gerard Caspe, Md, MD
Family Medicine — Payments: $10,176